Delivery of intraocular triamcinolone acetonide in the treatment of macular edema.

about

Delivery of intraocular triamcinolone acetonide in the treatment of macular edema.

Item

http://www.wikidata.org/entity/Q38168356

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Delivery of intraocular triamcinolone acetonide in the treatment of macular edema.

@en

type

Item

label

Delivery of intraocular triamcinolone acetonide in the treatment of macular edema.

@en

prefLabel

Delivery of intraocular triamcinolone acetonide in the treatment of macular edema.

@en

P1476

Delivery of intraocular triamcinolone acetonide in the treatment of macular edema.

@en

P2093

Aaron Pickrell

http://www.w3.org/2001/XMLSchema#string

Alon Harris

http://www.w3.org/2001/XMLSchema#string

Annahita Amireskandari

http://www.w3.org/2001/XMLSchema#string

Brent Siesky

http://www.w3.org/2001/XMLSchema#string

Erin Stewart

http://www.w3.org/2001/XMLSchema#string

Sandra Ngo

http://www.w3.org/2001/XMLSchema#string

P2860

Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.

Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.

Trans-Tenon's retrobulbar triamcinolone acetonide infusion for refractory diabetic macular edema after vitrectomy.

Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.

Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.

Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye.

Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective data from a randomized clinical trial.

Intravitreal triamcinolone prior to laser treatment of diabetic macular edema: 24-month results of a randomized controlled trial.

Transscleral drug delivery to the retina and choroid.

Novel nanoparticulate gel formulations of steroids for the treatment of macular edema.

P304

230-242

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/PHARMACEUTICS4010230

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259153353

http://www.w3.org/2001/XMLSchema#string

P698

24300190

http://www.w3.org/2001/XMLSchema#string

P932

3834899

http://www.w3.org/2001/XMLSchema#string